Stathopoulos, C.; Lumbroso-Le Rouic, L.; Moll, A.C.; Parulekar, M.; Maeder, P.; Doz, F.; Jenkinson, H.; Beck Popovic, M.; Chantada, G.; Munier, F.L.
Current Indications of Secondary Enucleation in Retinoblastoma Management: A Position Paper on Behalf of the European Retinoblastoma Group (EURbG). Cancers 2021, 13, 3392.
https://doi.org/10.3390/cancers13143392
AMA Style
Stathopoulos C, Lumbroso-Le Rouic L, Moll AC, Parulekar M, Maeder P, Doz F, Jenkinson H, Beck Popovic M, Chantada G, Munier FL.
Current Indications of Secondary Enucleation in Retinoblastoma Management: A Position Paper on Behalf of the European Retinoblastoma Group (EURbG). Cancers. 2021; 13(14):3392.
https://doi.org/10.3390/cancers13143392
Chicago/Turabian Style
Stathopoulos, Christina, Livia Lumbroso-Le Rouic, Annette C. Moll, Manoj Parulekar, Philippe Maeder, François Doz, Helen Jenkinson, Maja Beck Popovic, Guillermo Chantada, and Francis L. Munier.
2021. "Current Indications of Secondary Enucleation in Retinoblastoma Management: A Position Paper on Behalf of the European Retinoblastoma Group (EURbG)" Cancers 13, no. 14: 3392.
https://doi.org/10.3390/cancers13143392
APA Style
Stathopoulos, C., Lumbroso-Le Rouic, L., Moll, A. C., Parulekar, M., Maeder, P., Doz, F., Jenkinson, H., Beck Popovic, M., Chantada, G., & Munier, F. L.
(2021). Current Indications of Secondary Enucleation in Retinoblastoma Management: A Position Paper on Behalf of the European Retinoblastoma Group (EURbG). Cancers, 13(14), 3392.
https://doi.org/10.3390/cancers13143392
